Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 28 ... of shingles-related symptoms, including acute pain and PHN. About HCV and Protides Hepatitis C is a disease of the liver caused by the hepatitis C virus (HCV). It is estimated that ...
2009 NOV 23 ... repair of damage to the CNS (central nervous system), MS (Multiple Sclerosis), SARS, Hepatitis C and HIV. To receive future updates, via email including quarterly ... Marketing, Biopharmaceuticals, Biotechnology, Clinical Trial Research, Drugs, H1N1 Virus, Immunization, Infectious Disease, Novartis AG, Pharmaceutical Business, Pharmaceutical ...
2009 NOV 23 ... new issue of the Journal of the American Medical Association, "Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease," underscores the urgent need for Congress to ... and medical management referral program for chronic hepatitis B and chronic hepatitis C virus infection afflicting millions of Americans, the National Viral Hepatitis Roundtable ...
2009 NOV 23 ... concentrate was safe and well tolerated. No seroconversions were observed for HIV, hepatitisvirus, or human B19 virus," wrote T.J. Craig and colleagues. The ...
2009 NOV 23 ... members. Of interest, his serum transaminases were increased by similar to 3-fold and hepatitis serology and genotyping confirmed a diagnosis of hepatitis C virus (HCV) infection," ...
2009 NOV 23 ... "Entecavir is a potent inhibitor of hepatitis B virus (HBV) polymerase. The efficacy and safety of entecavir in nucleoside-naive patients with ...
2009 NOV 23 ... viremia were treated with antiviral medications. The most common clinical findings were hepatitis (62%), fever (54%), central nervous system alterations (46%), skin lesions (38%), ... "Quantification of herpes simplex virus (HSV) DNA in the peripheral blood is often used to evaluate patients suspected of having ...
2009 NOV 23 ... Data detailed in 'Towards a small animal model for hepatitis C' have been presented. "Hepatitis C virus (HCV) causes chronic liver disease and ...
2009 NOV 23 ... and 69%, P<0.001). These two variables had no impact on survival after LT, except in hepatitis C virus positive recipients. The multivariate Cox model confirmed a positive transplant ...
2009 NOV 23 ... nervous system (CNS) following infection with the neurotropic JHM strain of mouse hepatitisvirus (JHMV) is associated with an immune-mediated demyelinating disease. Treatment of ...
2009 NOV 23 ... "To evaluate the redox status in hepatocellular carcinoma (HCC) induced by hepatitis B virus (HBV), the most important aetiological factor in Taiwan, changes in O-2(center dot) ...
2009 NOV 23 ... to a study from Nagoya, Japan, "The recommended treatment for patients with chronic hepatitis C, pegylated interferon-alpha (PEG-IFN-alpha) plus ribavirin (RBV), does not provide ... (GWAS) to null virological response (NVR) in the treatment of patients with hepatitis C virus (HCV) genotype 1 within a Japanese population." "We found two SNPs near ...
2009 NOV 23 ... Scientists discuss in 'Hepatitis B and C virus-related carcinogenesis' new findings in hepatitis B virus. "Chronic hepatitis B virus (HBV) and hepatitis C ...
2009 NOV 23 ... According to a study from Taipei, Taiwan, "Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma. This population-based ...
2009 NOV 23 ... "Despite evidence suggesting that the majority of patients with hepatitis C virus (HCV) have psychiatric and substance use disorders, patients with these ...
2009 NOV 23 ... to a study from Havana, Cuba, "CIGB-230, a mixture of a DNA plasmid expressing hepatitis C virus (HCV) structural antigens and a HCV recombinant capsid protein, has demonstrated ...
2009 NOV 23 ... 11 per cent cryptogenic cirrhosis, 8 per cent hepatocellular carcinoma (HCC), 6 per cent hepatitis B virus, and 4 per cent metabolic disease. with autoimmune disease and HCC demonstrated the best ...
